Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Rani Therapeutics Holdings, Inc.RANI · Entity 6642 | Chief Technical Officer | September 27, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Rani Therapeutics Holdings, Inc.
Report date September 27, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 9,071 |
Reported balance
After 2026-09-27 transaction · row 1
1 source rowRow 1 · 2026-09-27 · Tax withholding · Disposed 309 · Balance 9,071 F1: Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 27, 2026 Filed Sep 29, 2026 20:36 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | Tax withholdingClass A Common Stock | 309 | $0.76 | $234.59 |
DisclosureSEC source: 0001193125-26-407648 · ownership.xml · nonDerivative · entry 1 Javadi Alireza · CIK 0002123843 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,071 F1 · kind: Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units. Read SEC document |
| June 27, 2026 Filed Jul 21, 2026 23:24 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | Tax withholdingClass A Common Stock | 309 | $0.74 | $228.66 |
DisclosureSEC source: 0002123843-26-000008 · ownership.xml · nonDerivative · entry 2 Javadi Alireza · CIK 0002123843 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,380 F1 · date: This transaction is being reported late due to inadvertent administrative oversight. F3 · kind: Represents shares withheld by and surrendered to the Issuer to satisfy tax withholding obligations in connection with the settlement and release of the restricted stock units. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 22:17 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | GrantStock Option (Right to Buy) · Derivative | 805,500 | $0.00 Strike: $0.88 | $0.00 |
DisclosureSEC source: 0002123843-26-000005 · ownership.xml · derivative · entry 1 Javadi Alireza · CIK 0002123843 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805,500 Underlying: Class A Common Stock · 805,500 shares Expires 2036-06-02 F1 · derivative.exercise_date: The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from April 1, 2026, subject to the Reporting Person's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through each such vesting date. Read SEC document |
| March 27, 2026 Filed Jul 21, 2026 23:24 UTC | Rani Therapeutics Holdings, Inc. RANI · Entity 6642 | SaleClass A Common Stock | 386 | $0.78 | $301.08 |
DisclosureSEC source: 0002123843-26-000008 · ownership.xml · nonDerivative · entry 1 Javadi Alireza · CIK 0002123843 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,689 F1 · date: This transaction is being reported late due to inadvertent administrative oversight. F2 · kind: Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of the restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.